{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:18:50Z","timestamp":1785543530782,"version":"3.56.0"},"reference-count":209,"publisher":"Elsevier","isbn-type":[{"value":"9780443345296","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.ircmb.2024.08.005","type":"book-chapter","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T19:58:38Z","timestamp":1726171118000},"page":"135-197","source":"Crossref","is-referenced-by-count":5,"title":["Expanding frontiers in liquid biopsy-discovery and validation of circulating biomarkers in renal cell carcinoma and bladder cancer"],"prefix":"10.1016","member":"78","reference":[{"issue":"8","key":"10.1016\/bs.ircmb.2024.08.005_bib1","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.urolonc.2012.06.010","article-title":"Plasma microRNA profiles for bladder cancer detection","volume":"31","author":"Adam","year":"2013","journal-title":"Urologic Oncology"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.08.005_bib2","first-page":"395","article-title":"Proteomics for early detection of non-muscle-invasive bladder cancer: Clinically useful urine protein biomarkers","volume":"12","author":"Ahn","year":"2022","journal-title":"Life (Basel)"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.08.005_bib3","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1590\/s1677-5538.ibju.2017.0404","article-title":"The diagnostic value of FNDC5\/irisin in renal cell cancer","volume":"44","author":"Altay","year":"2018","journal-title":"International Braz J Urol: Official Journal of the Brazilian Society of Urology"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.08.005_bib4","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1590\/s1677-5538.ibju.2017.0404","article-title":"The diagnostic value of FNDC5\/irisin in renal cell cancer","volume":"44","author":"Altay","year":"2018","journal-title":"International Braz J Urol: Official Journal of the Brazilian Society of Urology"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejps.2016.10.008","article-title":"Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression","volume":"98","author":"Andreu","year":"2017","journal-title":"European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and Carcinoma in Situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"European Urology"},{"issue":"5","key":"10.1016\/bs.ircmb.2024.08.005_bib7","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41379-018-0177-5","article-title":"Keratin 17 is a sensitive and specific biomarker of urothelial neoplasia","volume":"32","author":"Babu","year":"2019","journal-title":"Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology, Inc"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cca.2014.05.012","article-title":"Low- and high-grade bladder cancer appraisal via serum-based proteomics approach","volume":"436","author":"Bansal","year":"2014","journal-title":"Clinica Chimica Acta; International Journal of Clinical Chemistry"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jpba.2016.02.026","article-title":"Serum-based protein biomarkers of bladder cancer: A pre- and post-operative evaluation","volume":"124","author":"Bansal","year":"2016","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"issue":"6","key":"10.1016\/bs.ircmb.2024.08.005_bib10","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"28","key":"10.1016\/bs.ircmb.2024.08.005_bib11","doi-asserted-by":"crossref","first-page":"20058","DOI":"10.18632\/oncotarget.25102","article-title":"Single-cell genetic analysis validates cytopathological identification of circulating cancer cells in patients with clear cell renal cell carcinoma","volume":"9","author":"Broncy","year":"2018","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.08.005_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/diagnostics8030063","article-title":"Circulating tumor cells for the management of renal cell carcinoma","volume":"8","author":"Broncy","year":"2018","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/clinchem\/hvad133","article-title":"Diagnostic miRNA signatures in paired tumor, plasma, and urine specimens from renal cell carcinoma patients","volume":"70","author":"Bustos","year":"2024","journal-title":"Clinical Chemistry"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.08.005_bib14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2217\/bmm-2016-0348","article-title":"Influence of hematuria and infection on diagnostic accuracy of urinary LASP1: A new biomarker for bladder carcinoma","volume":"11","author":"Butt","year":"2017","journal-title":"Biomarkers in Medicine"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.08.005_bib15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.euf.2015.11.006","article-title":"Exosomal microRNAs Are diagnostic biomarkers and can mediate cell-cell communication in renal cell carcinoma","volume":"2","author":"Butz","year":"2016","journal-title":"European Urology Focus"},{"issue":"1\u20136","key":"10.1016\/bs.ircmb.2024.08.005_bib16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/CBM-2011-0176","article-title":"Renal cell carcinoma","volume":"9","author":"Cairns","year":"2011","journal-title":"Cancer Biomarkers: Section A of Disease Markers"},{"issue":"5","key":"10.1016\/bs.ircmb.2024.08.005_bib17","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1016\/j.ygeno.2020.06.003","article-title":"Novel molecular signatures and potential therapeutics in renal cell carcinomas: Insights from a comparative analysis of subtypes","volume":"112","author":"Caliskan","year":"2020","journal-title":"Genomics"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.eururo.2018.08.036","article-title":"Epidemiology of renal cell carcinoma","volume":"75","author":"Capitanio","year":"2019","journal-title":"European Urology"},{"issue":"17","key":"10.1016\/bs.ircmb.2024.08.005_bib19","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM199104253241702","article-title":"Measurement of prostate-specific antigen in serum as a screening test for prostate cancer","volume":"324","author":"Catalona","year":"1991","journal-title":"The New England Journal of Medicine"},{"issue":"6","key":"10.1016\/bs.ircmb.2024.08.005_bib20","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1021\/acs.jproteome.4c00199","article-title":"Comprehensive urinary proteome profiling analysis identifies diagnosis and relapse surveillance biomarkers for bladder cancer","volume":"23","author":"Chang","year":"2024","journal-title":"Journal of Proteome Research"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib21","doi-asserted-by":"crossref","first-page":"9038808","DOI":"10.1155\/2022\/9038808","article-title":"Urinary exosomal long noncoding RNA TERC as a noninvasive diagnostic and prognostic biomarker for bladder urothelial carcinoma","volume":"2022","author":"Chen","year":"2022","journal-title":"Journal of Immunology Research"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jprot.2013.04.024","article-title":"Identification of potential bladder cancer markers in urine by abundant-protein depletion coupled with quantitative proteomics","volume":"85","author":"Chen","year":"2013","journal-title":"Journal of Proteomics"},{"issue":"9","key":"10.1016\/bs.ircmb.2024.08.005_bib23","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1158\/1055-9965.EPI-14-0029","article-title":"External validation of a multiplex urinary protein panel for the detection of bladder cancer in a multicenter cohort","volume":"23","author":"Chen","year":"2014","journal-title":"Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology"},{"issue":"24","key":"10.1016\/bs.ircmb.2024.08.005_bib24","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1158\/1078-0432.CCR-18-1270","article-title":"PRMT5 circular RNA promotes metastasis of urothelial carcinoma of the bladder through sponging miR-30c to induce epithelial-mesenchymal transition","volume":"24","author":"Chen","year":"2018","journal-title":"Clinical Cancer Research: an Official Journal of the American Association for Cancer Research"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.08.005_bib25","first-page":"569","article-title":"Detection performance of circulating microRNA-210 for renal cell carcinoma: A meta-analysis","volume":"64","author":"Chen","year":"2018","journal-title":"Clinical Laboratory"},{"issue":"26","key":"10.1016\/bs.ircmb.2024.08.005_bib26","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016051","article-title":"MiR-101 acts as a novel bio-marker in the diagnosis of bladder carcinoma","volume":"98","author":"Chen","year":"2019","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.08.005_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/prca.202300033","article-title":"Integration of the cancer cell secretome and transcriptome reveals potential noninvasive diagnostic markers for bladder cancer","volume":"18","author":"Chen","year":"2024","journal-title":"Proteomics Clinical Applications"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12935-020-01703-z","article-title":"Cancer-related circular RNA: Diverse biological functions","volume":"21","author":"Cheng","year":"2021","journal-title":"Cancer Cell International"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.08.005_bib29","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3892\/ol.2013.1460","article-title":"Differential microRNA expression in renal cell carcinoma","volume":"6","author":"Cheng","year":"2013","journal-title":"Oncology Letters"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/iju.IJU_330_20","article-title":"Diagnostic accuracy of urinary aquaporin-1 as a biomarker for renal cell carcinoma","volume":"37","author":"Cheriyan","year":"2021","journal-title":"Indian Journal of Urology"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.08.005_bib31","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4149\/neo_2018_180318N185","article-title":"Downregulation of hsa_circ_0000285 serves as a prognostic biomarker for bladder cancer and is involved in cisplatin resistance","volume":"66","author":"Chi","year":"2019","journal-title":"Neoplasma"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib32","first-page":"1","article-title":"Surveillance strategies for renal cell carcinoma patients following nephrectomy","volume":"8","author":"Chin","year":"2006","journal-title":"Reviews in Urology"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib33","doi-asserted-by":"crossref","first-page":"21290","DOI":"10.1038\/s41598-020-77774-9","article-title":"Detection of urinary miRNAs for diagnosis of clear cell renal cell carcinoma","volume":"10","author":"Cochetti","year":"2020","journal-title":"Scientific Reports"},{"issue":"21","key":"10.1016\/bs.ircmb.2024.08.005_bib34","doi-asserted-by":"crossref","first-page":"35222","DOI":"10.18632\/oncotarget.16473","article-title":"Accuracy of the urine UCA1 for diagnosis of bladder cancer: A meta-analysis","volume":"8","author":"Cui","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.08.005_bib35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4103\/iju.IJU_69_21","article-title":"Apolipoprotein A1 as a novel urinary biomarker for diagnosis of bladder cancer: A systematic review and meta-analysis","volume":"37","author":"Dardeer","year":"2021","journal-title":"Indian Journal of Urology"},{"issue":"5","key":"10.1016\/bs.ircmb.2024.08.005_bib36","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/bjc.2012.20","article-title":"Serum 20S proteasome is elevated in patients with renal cell carcinoma and associated with poor prognosis","volume":"106","author":"de Martino","year":"2012","journal-title":"British Journal of Cancer"},{"issue":"8","key":"10.1016\/bs.ircmb.2024.08.005_bib37","first-page":"507","article-title":"Bladder cancer: Diagnosis and treatment","volume":"96","author":"DeGeorge","year":"2017","journal-title":"American Family Physician"},{"issue":"5","key":"10.1016\/bs.ircmb.2024.08.005_bib38","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.urolonc.2016.12.017","article-title":"Serum level of ANGPTL4 as a potential biomarker in renal cell carcinoma","volume":"35","author":"Dong","year":"2017","journal-title":"Urologic Oncology"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12957-018-1358-x","article-title":"Effectiveness of urine fibronectin as a non-invasive diagnostic biomarker in bladder cancer patients: A systematic review and meta-analysis","volume":"16","author":"Dong","year":"2018","journal-title":"World Journal of Surgical Oncology"},{"issue":"25","key":"10.1016\/bs.ircmb.2024.08.005_bib40","doi-asserted-by":"crossref","first-page":"40832","DOI":"10.18632\/oncotarget.16586","article-title":"Cell-free microRNA expression signatures in urine serve as novel noninvasive biomarkers for diagnosis and recurrence prediction of bladder cancer","volume":"8","author":"Du","year":"2017","journal-title":"Oncotarget"},{"issue":"48","key":"10.1016\/bs.ircmb.2024.08.005_bib41","doi-asserted-by":"crossref","first-page":"78850","DOI":"10.18632\/oncotarget.12880","article-title":"Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer","volume":"7","author":"Duan","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib42","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.euo.2019.06.006","article-title":"A novel, non-invasive test enabling bladder cancer detection in urine sediment of patients presenting with haematuria-A prospective multicentre performance evaluation of ADXBLADDER","volume":"3","author":"Dudderidge","year":"2020","journal-title":"European Urology Oncology"},{"issue":"12","key":"10.1016\/bs.ircmb.2024.08.005_bib43","doi-asserted-by":"crossref","first-page":"9545","DOI":"10.1007\/s13277-015-3722-6","article-title":"Integrative functional genetic-epigenetic approach for selecting genes as urine biomarkers for bladder cancer diagnosis","volume":"36","author":"Eissa","year":"2015","journal-title":"Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.08.005_bib44","doi-asserted-by":"crossref","first-page":"292.e19","DOI":"10.1016\/j.urolonc.2018.12.024","article-title":"Measurement of urinary level of a specific competing endogenous RNA network (FOS and RCAN mRNA\/ miR-324-5p, miR-4738-3p, \/lncRNA miR-497-HG) enables diagnosis of bladder cancer","volume":"37","author":"Eissa","year":"2019","journal-title":"Urologic Oncology"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib45","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.3389\/fonc.2019.01484","article-title":"A Specific blood signature reveals higher levels of S100A12: A potential bladder cancer diagnostic biomarker along with urinary engrailed-2 protein detection","volume":"9","author":"Elamin","year":"2020","journal-title":"Frontiers in Oncology"},{"issue":"7","key":"10.1016\/bs.ircmb.2024.08.005_bib46","doi-asserted-by":"crossref","first-page":"640.e1","DOI":"10.1016\/j.urolonc.2020.02.006","article-title":"Netrin-1: A new promising diagnostic marker for muscle invasion in bladder cancer","volume":"38","author":"El-Gamal","year":"2020","journal-title":"Urologic Oncology"},{"issue":"5","key":"10.1016\/bs.ircmb.2024.08.005_bib47","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1007\/s11033-021-06451-5","article-title":"Urinary exosomal microRNA-96-5p and microRNA-183-5p expression as potential biomarkers of bladder cancer","volume":"48","author":"El-Shal","year":"2021","journal-title":"Molecular Biology Reports"},{"issue":"6","key":"10.1016\/bs.ircmb.2024.08.005_bib48","doi-asserted-by":"crossref","first-page":"8075","DOI":"10.1007\/s13277-015-4698-y","article-title":"Circulating miR-205: A promising biomarker for the detection and prognosis evaluation of bladder cancer","volume":"37","author":"Fang","year":"2016","journal-title":"Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.08.005_bib49","doi-asserted-by":"crossref","first-page":"411","DOI":"10.11613\/BM.2017.043","article-title":"Detection of let-7 miRNAs in urine supernatant as potential diagnostic approach in non-metastatic clear-cell renal cell carcinoma","volume":"27","author":"Fedorko","year":"2017","journal-title":"Biochemia Medica (Zagreb)"},{"issue":"10","key":"10.1016\/bs.ircmb.2024.08.005_bib50","doi-asserted-by":"crossref","first-page":"23382","DOI":"10.3390\/ijms161023382","article-title":"Combination of MiR-378 and MiR-210 serum levels enables sensitive detection of renal cell carcinoma","volume":"16","author":"Fedorko","year":"2015","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib51","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13046-014-0067-8","article-title":"miR-19a acts as an oncogenic microRNA and is up-regulated in bladder cancer","volume":"33","author":"Feng","year":"2014","journal-title":"Journal of Experimental & Clinical Cancer Research: CR"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.08.005_bib52","doi-asserted-by":"crossref","first-page":"zcac025","DOI":"10.1093\/narcan\/zcac025","article-title":"Differential RNA aptamer affinity profiling on plasma as a potential diagnostic tool for bladder cancer","volume":"4","author":"Fjelstrup","year":"2022","journal-title":"NAR Cancer"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.08.005_bib53","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.urology.2011.05.045","article-title":"The detection of circulating tumor cells in metastatic and clinically localized urothelial carcinoma","volume":"78","author":"Flaig","year":"2011","journal-title":"Urology"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.08.005_bib54","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/bju.15601","article-title":"Early detection of kidney cancer using urinary proteins: A truly non-invasive strategy","volume":"129","author":"Flitcroft","year":"2022","journal-title":"BJU International"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib55","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jprot.2013.12.010","article-title":"Discovery and validation of urinary biomarkers for detection of renal cell carcinoma","volume":"98","author":"Frantzi","year":"2014","journal-title":"Journal of Proteomics"},{"issue":"16","key":"10.1016\/bs.ircmb.2024.08.005_bib56","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1158\/1078-0432.CCR-15-2715","article-title":"Development and validation of urine-based peptide biomarker panels for detecting bladder cancer in a multi-center study","volume":"22","author":"Frantzi","year":"2016","journal-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research"},{"issue":"5","key":"10.1016\/bs.ircmb.2024.08.005_bib57","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.euo.2018.04.015","article-title":"Plasma glycosaminoglycans as diagnostic and prognostic biomarkers in surgically treated renal cell carcinoma","volume":"1","author":"Gatto","year":"2018","journal-title":"European Urology Oncology"},{"issue":"9","key":"10.1016\/bs.ircmb.2024.08.005_bib58","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1093\/annonc\/mdr619","article-title":"Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: A CellSearch analysis","volume":"23","author":"Gazzaniga","year":"2012","journal-title":"Annals of Oncology: Official Journal of the European Society for Medical Oncology\/ESMO"},{"issue":"6","key":"10.1016\/bs.ircmb.2024.08.005_bib59","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.7314\/APJCP.2014.15.6.2395","article-title":"Bladder cancer biomarkers: Review and update","volume":"15","author":"Ghafouri-Fard","year":"2014","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"issue":"7","key":"10.1016\/bs.ircmb.2024.08.005_bib60","first-page":"661","article-title":"H19 non-coding RNA in urine cells detects urothelial carcinoma: A pilot study","volume":"22","author":"Gielchinsky","year":"2017","journal-title":"Biomarkers: Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib61","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12967-016-1043-1","article-title":"A multiplex urinary immunoassay for bladder cancer detection: Analysis of a Japanese cohort","volume":"14","author":"Goodison","year":"2016","journal-title":"Journal of Translational Medicine"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.08.005_bib62","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11255-019-02328-6","article-title":"Urinary micro-RNA expressions and protein concentrations may differentiate bladder cancer patients from healthy controls","volume":"52","author":"G\u00fcll\u00fc Amuran","year":"2020","journal-title":"International Urology and Nephrology"},{"issue":"10","key":"10.1016\/bs.ircmb.2024.08.005_bib63","doi-asserted-by":"crossref","first-page":"14329","DOI":"10.1007\/s13277-016-5223-7","article-title":"Cytokeratin-19 fragment in the diagnosis of bladder carcinoma","volume":"37","author":"Guo","year":"2016","journal-title":"Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine"},{"issue":"6","key":"10.1016\/bs.ircmb.2024.08.005_bib64","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.urolonc.2009.01.027","article-title":"A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer","volume":"28","author":"Hanke","year":"2010","journal-title":"Urologic Oncology"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib65","first-page":"186","article-title":"miRNA-27b-3p, let-7f-5p and miRNA-142-5p can be used in a novel serum diagnostic panel for clear cell renal cell carcinoma","volume":"29","author":"He","year":"2024"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib66","first-page":"46","article-title":"Long noncoding RNA GIHCG is a potential diagnostic and prognostic biomarker and therapeutic target for renal cell carcinoma","volume":"22","author":"He","year":"2018","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib67","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s43856-022-00088-6","article-title":"Early-stage multi-cancer detection using an extracellular vesicle protein-based blood test","volume":"2","author":"Hinestrosa","year":"2022","journal-title":"Communications Medicine (Lond)"},{"issue":"6","key":"10.1016\/bs.ircmb.2024.08.005_bib68","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.21037\/tau-20-1327","article-title":"Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?","volume":"10","author":"Humayun-Zakaria","year":"2021","journal-title":"Translational Andrology and Urology"},{"issue":"9","key":"10.1016\/bs.ircmb.2024.08.005_bib69","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1111\/cas.15438","article-title":"Extracellular vesicles expressing CEACAM proteins in the urine of bladder cancer patients","volume":"113","author":"Igami","year":"2022","journal-title":"Cancer Science"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.08.005_bib70","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/ijc.29041","article-title":"Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer","volume":"136","author":"Jiang","year":"2015","journal-title":"International Journal of Cancer"},{"issue":"11","key":"10.1016\/bs.ircmb.2024.08.005_bib71","doi-asserted-by":"crossref","first-page":"10844","DOI":"10.18632\/aging.103297","article-title":"Aberrantly glycosylated integrin \u03b13\u03b21 is a unique urinary biomarker for the diagnosis of bladder cancer","volume":"12","author":"Jin","year":"2020","journal-title":"Aging"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib72","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1590\/s1677-5538.ibju.2016.0316","article-title":"SCUBE1: A promising biomarker in renal cell cancer","volume":"43","author":"Karag\u00fczel","year":"2017","journal-title":"International Braz J Urol: Official Journal of the Brazilian Society of Urology"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib73","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/00365590410002500","article-title":"Urinary nuclear matrix protein 22 for diagnosis of renal cell carcinoma","volume":"39","author":"Kaya","year":"2005","journal-title":"Scandinavian Journal of Urology and Nephrology"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib74","first-page":"10","article-title":"A systematic review of circulating tumor cells in renal cell carcinoma","volume":"3","author":"Khatami","year":"2021","journal-title":"Translational Research Urology"},{"issue":"9","key":"10.1016\/bs.ircmb.2024.08.005_bib75","first-page":"E285","article-title":"Detection of circulating tumour cells and their potential use as a biomarker for advanced renal cell carcinoma","volume":"13","author":"Kim","year":"2019","journal-title":"Canadian Urological Association Journal = Journal de l\u2019Association des Urologues du Canada"},{"issue":"5","key":"10.1016\/bs.ircmb.2024.08.005_bib76","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3390\/jcm9051372","article-title":"Detection of circulating tumor cells in renal cell carcinoma: Disease stage correlation and molecular characterization","volume":"9","author":"Klezl","year":"2020","journal-title":"Journal of Clinical Medicine"},{"issue":"9","key":"10.1016\/bs.ircmb.2024.08.005_bib77","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/cncy.22727","article-title":"Dual immunocytochemical staining of annexin A10 and p53 in low-grade and papillary urothelial carcinoma contributes to improvement of diagnostic accuracy in urine cytology","volume":"131","author":"Kobayashi","year":"2023","journal-title":"Cancer Cytopathology"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib78","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s12967-024-04951-z","article-title":"Identification of novel protein biomarkers from the blood and urine for the early diagnosis of bladder cancer via proximity extension analysis","volume":"22","author":"Kong","year":"2024","journal-title":"Journal of Translational Medicine"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib79","doi-asserted-by":"crossref","first-page":"8434","DOI":"10.1038\/s41598-019-44944-3","article-title":"Detection of novel biomarkers for early detection of non-muscle-invasive bladder cancer using competing endogenous RNA network analysis","volume":"9","author":"Kouhsar","year":"2019","journal-title":"Scientific Reports"},{"issue":"10","key":"10.1016\/bs.ircmb.2024.08.005_bib80","doi-asserted-by":"crossref","first-page":"6554","DOI":"10.21037\/tcr-20-1990","article-title":"Review of non-invasive urinary biomarkers in bladder cancer","volume":"9","author":"Lee","year":"2020","journal-title":"Translational Cancer Research"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.976407","article-title":"Alpha-2-macroglobulin as a novel diagnostic biomarker for human bladder cancer in urinary extracellular vesicles","volume":"12","author":"Lee","year":"2022","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib82","doi-asserted-by":"crossref","first-page":"1019391","DOI":"10.3389\/fonc.2022.1019391","article-title":"Urine exosomes as biomarkers in bladder cancer diagnosis and prognosis: From functional roles to clinical significance","volume":"12","author":"Lee","year":"2022","journal-title":"Frontiers in Oncology"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.08.005_bib83","first-page":"331","article-title":"The increased excretion of urinary orosomucoid 1 as a useful biomarker for bladder cancer","volume":"6","author":"Li","year":"2016","journal-title":"American Journal of Cancer Research"},{"issue":"1A","key":"10.1016\/bs.ircmb.2024.08.005_bib84","first-page":"377","article-title":"Cadherin-6 gene expression in conventional renal cell carcinoma: A useful marker to detect circulating tumor cells","volume":"25","author":"Li","year":"2005","journal-title":"Anticancer Research"},{"issue":"10","key":"10.1016\/bs.ircmb.2024.08.005_bib85","doi-asserted-by":"crossref","first-page":"18014","DOI":"10.1002\/jcb.29104","article-title":"lncRNA TUC338 is a potential diagnostic biomarker for bladder cancer","volume":"120","author":"Li","year":"2019","journal-title":"Journal of Cellular Biochemistry"},{"issue":"25","key":"10.1016\/bs.ircmb.2024.08.005_bib86","doi-asserted-by":"crossref","first-page":"16113","DOI":"10.1021\/acsnano.4c00280","article-title":"Choline phosphate-grafted nanozymes as universal extracellular vesicle probes for bladder cancer detection","volume":"18","author":"Li","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib87","doi-asserted-by":"crossref","first-page":"1076303","DOI":"10.3389\/fonc.2022.1076303","article-title":"A four-microRNA panel in serum may serve as potential biomarker for renal cell carcinoma diagnosis","volume":"12","author":"Li","year":"2023","journal-title":"Frontiers in Oncology"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib88","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/pmic.201000810","article-title":"Proteomic analysis of urinary biomarker candidates for nonmuscle invasive bladder cancer","volume":"12","author":"Lind\u00e9n","year":"2012","journal-title":"Proteomics"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.08.005_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0281873","article-title":"CDCP1 (CUB domain containing protein 1) is a potential urine-based biomarker in the diagnosis of low-grade urothelial carcinoma","volume":"18","author":"Liu","year":"2023","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.08.005_bib90","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/jcmm.17152","article-title":"The emerging roles of exosomal long non\u2010coding RNAs in bladder cancer","volume":"26","author":"Liu","year":"2022","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"6","key":"10.1016\/bs.ircmb.2024.08.005_bib91","first-page":"5075","article-title":"Identification of dysregulated serum miR-508-3p and miR-885-5p as potential diagnostic biomarkers of clear cell renal carcinoma","volume":"20","author":"Liu","year":"2019","journal-title":"Molecular Medicine Reports"},{"issue":"37","key":"10.1016\/bs.ircmb.2024.08.005_bib92","doi-asserted-by":"crossref","first-page":"59877","DOI":"10.18632\/oncotarget.10979","article-title":"Combined cell surface carbonic anhydrase 9 and CD147 antigens enable high-efficiency capture of circulating tumor cells in clear cell renal cell carcinoma patients","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/bs.ircmb.2024.08.005_bib93","first-page":"2500","article-title":"A non-invasive miRNA based assay to detect bladder cancer in cell-free urine","volume":"7","author":"Long","year":"2015","journal-title":"American Journal of Translational Research"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib94","doi-asserted-by":"crossref","first-page":"36.e7","DOI":"10.1016\/j.urolonc.2016.07.012","article-title":"miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinoma","volume":"35","author":"Lou","year":"2017","journal-title":"Urologic Oncology"},{"issue":"5","key":"10.1016\/bs.ircmb.2024.08.005_bib95","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1080\/1354750X.2024.2358312","article-title":"Testing the accuracy of a four serum microRNA panel for the detection of primary bladder cancer: a discovery and validation study","volume":"29","author":"Lu","year":"2024","journal-title":"Biomarkers: Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib96","doi-asserted-by":"crossref","first-page":"6736","DOI":"10.12659\/MSM.915950","article-title":"Diagnostic utility of serum golgi phosphoprotein 3 in bladder cancer patients","volume":"25","author":"Lu","year":"2019","journal-title":"Medical Science Monitor: International Medical Journal of Experimental and Clinical Research"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib97","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/14756366.2017.1411350","article-title":"Plasmatic carbonic anhydrase IX as a diagnostic marker for clear cell renal cell carcinoma","volume":"33","author":"Lucarini","year":"2018","journal-title":"Journal of Enzyme Inhibition and Medicinal Chemistry"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib98","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1186\/s12885-023-11510-0","article-title":"Circular RNA CCT3 is a unique molecular marker in bladder cancer","volume":"23","author":"Luo","year":"2023","journal-title":"BMC Cancer"},{"issue":"50","key":"10.1016\/bs.ircmb.2024.08.005_bib99","doi-asserted-by":"crossref","first-page":"87710","DOI":"10.18632\/oncotarget.21197","article-title":"Comparison of isolation platforms for detection of circulating renal cell carcinoma cells","volume":"8","author":"Maertens","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib100","doi-asserted-by":"crossref","first-page":"121","DOI":"10.31557\/APJCP.2023.24.1.121","article-title":"Urine micro-RNA signature as a potential non-invasive diagnostic biomarker in bladder cancer","volume":"24","author":"Mamdouh","year":"2023","journal-title":"Asian Pacific Journal of Cancer Prevention: APJCP"},{"issue":"6","key":"10.1016\/bs.ircmb.2024.08.005_bib101","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.18632\/oncotarget.23872","article-title":"Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer","volume":"9","author":"Masuda","year":"2018","journal-title":"Oncotarget"},{"issue":"15","key":"10.1016\/bs.ircmb.2024.08.005_bib102","doi-asserted-by":"crossref","first-page":"24668","DOI":"10.18632\/oncotarget.14969","article-title":"MiR-21-5p in urinary extracellular vesicles is a novel biomarker of urothelial carcinoma","volume":"8","author":"Matsuzaki","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.08.005_bib103","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/(SICI)1097-0142(19990801)86:3<492::AID-CNCR18>3.0.CO;2-R","article-title":"The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN\/CA9","volume":"86","author":"McKiernan","year":"1999","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib104","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00216-011-5057-5","article-title":"14-3-3 protein beta\/alpha as a urinary biomarker for renal cell carcinoma: proteomic analysis of cyst fluid","volume":"401","author":"Minamida","year":"2011","journal-title":"Analytical and Bioanalytical Chemistry"},{"issue":"11","key":"10.1016\/bs.ircmb.2024.08.005_bib105","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1111\/cas.13384","article-title":"Diagnostic and prognostic role of urinary collagens in primary human bladder cancer","volume":"108","author":"Miyake","year":"2017","journal-title":"Cancer Science"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib106","article-title":"Aurora kinase A is a biomarker for bladder cancer detection and contributes to its aggressive behavior","volume":"7","author":"Mobley","year":"2017","journal-title":"Scientific Reports [Internet]"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.08.005_bib107","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1001\/jamaoncol.2015.0213","article-title":"Evaluation of urine aquaporin 1 and perilipin 2 concentrations as biomarkers to screen for renal cell carcinoma","volume":"1","author":"Morrissey","year":"2015","journal-title":"JAMA Oncology"},{"issue":"11","key":"10.1016\/bs.ircmb.2024.08.005_bib108","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.6004\/jnccn.2019.0054","article-title":"NCCN guidelines insights: Kidney cancer, version 2.2020","volume":"17","author":"Motzer","year":"2019","journal-title":"Journal of the National Comprehensive Cancer Network: JNCCN"},{"issue":"5","key":"10.1016\/bs.ircmb.2024.08.005_bib109","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s11255-018-1841-x","article-title":"MicroRNA-15a expression measured in urine samples as a potential biomarker of renal cell carcinoma","volume":"50","author":"Mytsyk","year":"2018","journal-title":"International Urology and Nephrology"},{"issue":"24","key":"10.1016\/bs.ircmb.2024.08.005_bib110","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12894-024-01481-0","article-title":"Increased level of serum leucine-rich-alpha-2-glycoprotein 1 in patients with clear cell renal cell carcinoma","volume":"24","author":"Nakanishi","year":"2024","journal-title":"BMC Urology"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.08.005_bib111","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3233\/CBM-150472","article-title":"Urine CXCL1 as a biomarker for tumor detection and outcome prediction in bladder cancer","volume":"15","author":"Nakashima","year":"2015","journal-title":"Cancer Biomarkers: Section A of Disease Markers"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib112","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67929-z","article-title":"Circulating proteomic signature for detection of biomarkers in bladder cancer patients","volume":"10","author":"Nedjadi","year":"2020","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib113","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.urolonc.2020.08.016","article-title":"Urinary biomarkers in bladder cancer: A review of the current landscape and future directions","volume":"39","author":"Ng","year":"2021","journal-title":"Urologic Oncology: Seminars and Original Investigations"},{"issue":"15","key":"10.1016\/bs.ircmb.2024.08.005_bib114","doi-asserted-by":"crossref","first-page":"7913","DOI":"10.3390\/ijms22157913","article-title":"Identification of miR-20a-5p as robust normalizer for urine microRNA studies in renal cell carcinoma and a profile of dysregulated microRNAs","volume":"22","author":"Oto","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib115","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13046-020-01600-3","article-title":"MicroRNA-30a-5pme: A novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma in tissue and urine samples","volume":"39","author":"Outeiro-Pinho","year":"2020","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"8","key":"10.1016\/bs.ircmb.2024.08.005_bib116","first-page":"2951","article-title":"Detection of serum long non-coding RNA UCA1 and circular RNAs for the diagnosis of bladder cancer and prediction of recurrence","volume":"12","author":"Pan","year":"2019","journal-title":"International Journal of Clinical and Experimental Pathology"},{"issue":"25","key":"10.1016\/bs.ircmb.2024.08.005_bib117","doi-asserted-by":"crossref","first-page":"40412","DOI":"10.18632\/oncotarget.16341","article-title":"Urinary RKIP\/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma","volume":"8","author":"Papale","year":"2017","journal-title":"Oncotarget"},{"issue":"29","key":"10.1016\/bs.ircmb.2024.08.005_bib118","doi-asserted-by":"crossref","first-page":"20658","DOI":"10.18632\/oncotarget.25057","article-title":"microRNA profiles in urine by next-generation sequencing can stratify bladder cancer subtypes","volume":"9","author":"Pardini","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/251403","article-title":"Serum and urine biomarkers for human renal cell carcinoma","volume":"2015","author":"Pastore","year":"2015","journal-title":"Disease Markers"},{"issue":"16","key":"10.1016\/bs.ircmb.2024.08.005_bib120","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2018100836","article-title":"Past, present, and future of circRNAs","volume":"38","author":"Patop","year":"2019","journal-title":"The EMBO Journal"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib121","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.814228","article-title":"Investigating urinary circular RNA biomarkers for improved detection of renal cell carcinoma","volume":"11","author":"Peter","year":"2022","journal-title":"Frontiers in Oncology"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.08.005_bib122","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3233\/CBM-190242","article-title":"Emerging role of secreted miR-210-3p as potential biomarker for clear cell renal cell carcinoma metastasis","volume":"27","author":"Petrozza","year":"2020","journal-title":"Cancer Biomarkers: Section A of Disease Markers"},{"issue":"41","key":"10.1016\/bs.ircmb.2024.08.005_bib123","doi-asserted-by":"crossref","first-page":"69551","DOI":"10.18632\/oncotarget.18449","article-title":"Secreted miR-210-3p as non-invasive biomarker in clear cell renal cell carcinoma","volume":"8","author":"Petrozza","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.08.005_bib124","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ijc.31849","article-title":"Urinary cell-free microRNA biomarker could discriminate bladder cancer from benign hematuria","volume":"144","author":"Piao","year":"2019","journal-title":"International Journal of Cancer"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.08.005_bib125","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s40291-016-0192-5","article-title":"Epithelial to mesenchymal transition in renal cell carcinoma: Implications for cancer therapy","volume":"20","author":"Piva","year":"2016","journal-title":"Molecular Diagnosis & Therapy"},{"issue":"5","key":"10.1016\/bs.ircmb.2024.08.005_bib126","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.ajpath.2012.01.034","article-title":"miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer","volume":"180","author":"Puerta-Gil","year":"2012","journal-title":"The American Journal of Pathology"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.08.005_bib127","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11010-021-04279-y","article-title":"MN\/CA9 gene expression as a potential tumor marker for renal cell carcinoma","volume":"477","author":"Raina","year":"2022","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"6","key":"10.1016\/bs.ircmb.2024.08.005_bib128","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/PAT.0000000000000145","article-title":"Tumour necrosis factor receptor-associated factor-1 (TRAF-1) expression is increased in renal cell carcinoma patient serum but decreased in cancer tissue compared with normal: Potential biomarker significance","volume":"46","author":"Rajandram","year":"2014","journal-title":"Pathology"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib129","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1479-5876-10-55","article-title":"Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma","volume":"10","author":"Redova","year":"2012","journal-title":"Journal of Translational Medicine"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.08.005_bib130","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.eururo.2012.01.017","article-title":"Prognostic role and HER2 expression of circulating tumor cells in peripheral blood of patients prior to radical cystectomy: A prospective study","volume":"61","author":"Rink","year":"2012","journal-title":"European Urology"},{"issue":"6","key":"10.1016\/bs.ircmb.2024.08.005_bib131","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1016\/j.juro.2013.06.011","article-title":"Multiplex protein signature for the detection of bladder cancer in voided urine samples","volume":"190","author":"Rosser","year":"2013","journal-title":"The Journal of Urology"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib132","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/medsci8010015","article-title":"Epidemiology of bladder cancer","volume":"8","author":"Saginala","year":"2020","journal-title":"Medical Sciences (Basel)"},{"issue":"5","key":"10.1016\/bs.ircmb.2024.08.005_bib133","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1016\/j.clgc.2016.04.002","article-title":"Expression level of urinary microRNA-146a-5p is increased in patients with bladder cancer and decreased in those after transurethral resection","volume":"14","author":"Sasaki","year":"2016","journal-title":"Clinical Genitourinary Cancer"},{"issue":"22","key":"10.1016\/bs.ircmb.2024.08.005_bib134","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1158\/1078-0432.CCR-18-1496","article-title":"KIM-1 as a blood-based marker for early detection of kidney cancer: A prospective nested case-control study","volume":"24","author":"Scelo","year":"2018","journal-title":"Clinical Cancer Research: an Official Journal of the American Association for Cancer Research"},{"issue":"22","key":"10.1016\/bs.ircmb.2024.08.005_bib135","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1158\/1078-0432.CCR-18-1496","article-title":"KIM-1 as a blood-based marker for early detection of kidney cancer: A prospective nested case-control study","volume":"24","author":"Scelo","year":"2018","journal-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research"},{"issue":"15","key":"10.1016\/bs.ircmb.2024.08.005_bib136","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1158\/1078-0432.CCR-09-0226","article-title":"Prediction of muscle-invasive bladder cancer using urinary proteomics","volume":"15","author":"Schiffer","year":"2009","journal-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.08.005_bib137","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s12253-014-9765-y","article-title":"Diagnostic evaluation of urinary angiogenin (ANG) and clusterin (CLU) as biomarker for bladder cancer","volume":"20","author":"Shabayek","year":"2014","journal-title":"Pathology Oncology Research: POR"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib138","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/dc.23332","article-title":"Ubiquilin2 as a novel marker for detection of urothelial carcinoma cells in urine","volume":"44","author":"Shimada","year":"2016","journal-title":"Diagnostic Cytopathology"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.08.005_bib139","first-page":"1049","article-title":"Detection of cadherin-6 mRNA by nested RT-PCR as a potential marker for circulating cancer cells in renal cell carcinoma","volume":"23","author":"Shimazui","year":"2003","journal-title":"International Journal of Oncology"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12967-016-0783-2","article-title":"A multiplex immunoassay for the non-invasive detection of bladder cancer","volume":"14","author":"Shimizu","year":"2016","journal-title":"Journal of Translational Medicine"},{"issue":"7","key":"10.1016\/bs.ircmb.2024.08.005_bib141","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1134\/S0006297922070070","article-title":"Non-invasive diagnostics of renal cell carcinoma using ultrasensitive immunodetection of cancer-retina antigens","volume":"87","author":"Shlyapnikov","year":"2022","journal-title":"Biochemistry. Biokhimiia"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib142","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.08.005_bib143","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s11010-021-04299-8","article-title":"Autophagy-associated HMGB-1 as a novel potential circulating non-invasive diagnostic marker for detection of Urothelial Carcinoma of Bladder","volume":"477","author":"Singh","year":"2022","journal-title":"Molecular and Cellular Biochemistry"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib144","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12957-021-02268-5","article-title":"Clinical significance of circulating tumour cells and Ki-67 in renal cell carcinoma","volume":"19","author":"Song","year":"2021","journal-title":"World Journal of Surgical Oncology"},{"issue":"10","key":"10.1016\/bs.ircmb.2024.08.005_bib145","doi-asserted-by":"crossref","first-page":"6755","DOI":"10.1111\/jcmm.14553","article-title":"Urinary exosome miR\u201030c\u20105p as a biomarker of clear cell renal cell carcinoma that inhibits progression by targeting HSPA5.","volume":"23","author":"Song","year":"2019","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib146","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4149\/neo_2018_181214N970","article-title":"Identification of urinary hsa_circ _0137439 as potential biomarker and tumor regulator of bladder cancer","volume":"67","author":"Song","year":"2020","journal-title":"Neoplasma"},{"issue":"12","key":"10.1016\/bs.ircmb.2024.08.005_bib147","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s00345-018-2380-x","article-title":"An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer","volume":"36","author":"Soria","year":"2018","journal-title":"World Journal of Urology"},{"issue":"6","key":"10.1016\/bs.ircmb.2024.08.005_bib148","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.4149\/neo_2019_190124N74","article-title":"The significance of calprotectin, CD147, APOA4 and DJ-1 in non-invasive detection of urinary bladder carcinoma","volume":"66","author":"Soukup","year":"2019","journal-title":"Neoplasma"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib149","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000368166","article-title":"Panel of urinary diagnostic markers for non-invasive detection of primary and recurrent urothelial urinary bladder carcinoma","volume":"95","author":"Soukup","year":"2015","journal-title":"Urologia Internationalis"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.08.005_bib150","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1111\/ajco.12165","article-title":"Clinical utility of urinary soluble Fas in screening for bladder cancer","volume":"12","author":"Srivastava","year":"2016","journal-title":"Asia-Pacific Journal of Clinical Oncology"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.08.005_bib151","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/21681805.2017.1313309","article-title":"Evaluation of the diagnostic accuracy of UBC\u00ae Rapid in bladder cancer: A Swedish multicentre study.","volume":"51","author":"Styrke","year":"2017","journal-title":"Scandinavian Journal of Urology"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.08.005_bib152","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1158\/1055-9965.EPI-12-1156","article-title":"Composite three-marker assay for early detection of kidney cancer","volume":"22","author":"Su Kim","year":"2013","journal-title":"Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib153","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12943-019-1002-6","article-title":"Circular RNAs in cancer: Emerging functions in hallmarks, stemness, resistance and roles as potential biomarkers","volume":"18","author":"Su","year":"2019","journal-title":"Molecular Cancer"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.08.005_bib154","doi-asserted-by":"crossref","first-page":"882","DOI":"10.4143\/crt.2021.642","article-title":"Next-generation proteomics\u2013based discovery, verification, and validation of urine biomarkers for bladder cancer diagnosis.","volume":"54","author":"Suh","year":"2022","journal-title":"Cancer Research and Treatment"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib155","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","author":"Sung","year":"2021","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib156","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11255-021-03074-4","article-title":"Serum irisin is a novel biomarker for bladder cancer detection","volume":"54","author":"Taken","year":"2022","journal-title":"International Urology and Nephrology"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib157","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ctrv.2018.05.012","article-title":"Novel urinary biomarkers for the detection of bladder cancer: A systematic review","volume":"69","author":"Tan","year":"2018","journal-title":"Cancer Treatment Reviews"},{"issue":"12","key":"10.1016\/bs.ircmb.2024.08.005_bib158","article-title":"Lamprey immunity protein enables early detection and recurrence monitoring for bladder cancer through recognizing Neu5Gc-modified uromodulin glycoprotein in urine","volume":"1868","author":"Teng","year":"2022","journal-title":"Biochimica et Biophysica Acta (BBA)\u2014Molecular Basis of Disease"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.08.005_bib159","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/iju.15338","article-title":"Urinary markers for bladder cancer diagnosis: A review of current status and future challenges","volume":"31","author":"Tomiyama","year":"2024","journal-title":"International Journal of Urology: Official Journal of the Japanese Urological Association"},{"issue":"7","key":"10.1016\/bs.ircmb.2024.08.005_bib160","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/s41416-022-01860-0","article-title":"EphA2 on urinary extracellular vesicles as a novel biomarker for bladder cancer diagnosis and its effect on the invasiveness of bladder cancer","volume":"127","author":"Tomiyama","year":"2022","journal-title":"British Journal of Cancer"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib161","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3233\/CBM-160676","article-title":"Functional analysis of serum microRNAs miR-21 and miR-106a in renal cell carcinoma","volume":"18","author":"Tusong","year":"2017","journal-title":"Cancer Biomarkers: Section A of Disease Markers"},{"issue":"52","key":"10.1016\/bs.ircmb.2024.08.005_bib162","doi-asserted-by":"crossref","first-page":"86290","DOI":"10.18632\/oncotarget.13382","article-title":"A microRNA biomarker panel for the non-invasive detection of bladder cancer","volume":"7","author":"Urquidi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib163","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/5584_2021_700","article-title":"Cytokines in renal cell carcinoma: A step towards earlier detection and targeted therapy","volume":"1374","author":"Vargov\u00e1","year":"2022","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.08.005_bib164","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12291-020-00881-x","article-title":"Association of miRNA 30c, miRNA 181a and miRNA 570 SNPs with bladder cancer risk in north indian population: A pilot study","volume":"36","author":"Verma","year":"2021","journal-title":"Indian Journal of Clinical Biochemistry"},{"issue":"6","key":"10.1016\/bs.ircmb.2024.08.005_bib165","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/cyt.12463","article-title":"Cytokeratin 20 immunocytochemistry on urine sediments: A potential low-cost adjunct to cytology in the diagnosis of low-grade urothelial carcinoma","volume":"28","author":"Wadhwa","year":"2017","journal-title":"Cytopathology: Official Journal of the British Society for Clinical Cytology"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib166","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s41544-019-0023-z","article-title":"Circulating miR-200a is a novel molecular biomarker for early-stage renal cell carcinoma","volume":"1","author":"Wang","year":"2019","journal-title":"ExRNA"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib167","doi-asserted-by":"crossref","first-page":"7610","DOI":"10.1038\/srep07610","article-title":"A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma","volume":"5","author":"Wang","year":"2015","journal-title":"Scientific Reports"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.08.005_bib168","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000517310","article-title":"The early diagnostic and prognostic value of BIRC5 in clear-cell renal cell carcinoma based on the cancer genome atlas data","volume":"106","author":"Wang","year":"2022","journal-title":"Urologia Internationalis"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.08.005_bib169","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/jcb.27347","article-title":"Serum exosomal miR-210 as a potential biomarker for clear cell renal cell carcinoma","volume":"120","author":"Wang","year":"2019","journal-title":"Journal of Cellular Biochemistry"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.08.005_bib170","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11255-023-03781-0","article-title":"Early diagnosis and prognostic potential of RAC3 in bladder tumor","volume":"56","author":"Wang","year":"2024","journal-title":"International Urology and Nephrology"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib171","doi-asserted-by":"crossref","first-page":"9307","DOI":"10.12659\/MSM.912018","article-title":"Determination of serum exosomal H19 as a noninvasive biomarker for bladder cancer diagnosis and prognosis","volume":"24","author":"Wang","year":"2018","journal-title":"Medical Science Monitor: International Medical Journal of Experimental and Clinical Research"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib172","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.12659\/MSM.907075","article-title":"Clinical significance of serological and urological levels of bladder cancer-specific antigen-1 (BLCA-1) in bladder cancer","volume":"24","author":"Wang","year":"2018","journal-title":"Medical Science Monitor: International Medical Journal of Experimental and Clinical Research"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib173","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12943-020-01266-7","article-title":"Circular RNAs in renal cell carcinoma: Implications for tumorigenesis, diagnosis, and therapy","volume":"19","author":"Wang","year":"2020","journal-title":"Molecular Cancer"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.08.005_bib174","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.clgc.2012.01.001","article-title":"Expression of microRNAs in the urine of patients with bladder cancer","volume":"10","author":"Wang","year":"2012","journal-title":"Clinical Genitourinary Cancer"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.08.005_bib175","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/1724600820926685","article-title":"Circulating lncRNAs as noninvasive biomarkers in bladder cancer: A diagnostic meta-analysis based on 15 published articles","volume":"35","author":"Wang","year":"2020","journal-title":"The International Journal of Biological Markers"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib176","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12935-023-03187-z","article-title":"A serum panel of three microRNAs may serve as possible biomarkers for kidney renal clear cell carcinoma","volume":"24","author":"Wen","year":"2024","journal-title":"Cancer Cell International"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.08.005_bib177","doi-asserted-by":"crossref","first-page":"506","DOI":"10.18632\/oncotarget.1529","article-title":"Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma","volume":"5","author":"White","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib178","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2015.48","article-title":"A serum-circulating long noncoding RNA signature can discriminate between patients with clear cell renal cell carcinoma and healthy controls","volume":"5","author":"Wu","year":"2016","journal-title":"Oncogenesis"},{"issue":"9","key":"10.1016\/bs.ircmb.2024.08.005_bib179","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025787","article-title":"MicroRNAs in renal cell carcinoma: Diagnostic implications of serum miR-1233 levels","volume":"6","author":"Wulfken","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.08.005_bib180","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1002\/jcb.26492","article-title":"Circular RNA hsa_circ_0003221 (circPTK2) promotes the proliferation and migration of bladder cancer cells","volume":"119","author":"Xu","year":"2018","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib181","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12943-017-0714-8","article-title":"Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1","volume":"16","author":"Xue","year":"2017","journal-title":"Molecular Cancer"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib182","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.urology.2017.03.013","article-title":"Serum microRNA expression profiling: Potential diagnostic implications of a panel of serum microRNAs for clear cell renal cell cancer","volume":"104","author":"Yadav","year":"2017","journal-title":"Urology"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.08.005_bib183","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1349-7006.2010.01816.x","article-title":"MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: Correlation with stage and grade, and comparison with urinary cytology","volume":"102","author":"Yamada","year":"2011","journal-title":"Cancer Science"},{"issue":"7","key":"10.1016\/bs.ircmb.2024.08.005_bib184","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/kjm2.12845","article-title":"The value of urinary exosomal microRNA-21 in the early diagnosis and prognosis of bladder cancer","volume":"40","author":"Yang","year":"2024","journal-title":"The Kaohsiung Journal of Medical Sciences"},{"issue":"11","key":"10.1016\/bs.ircmb.2024.08.005_bib185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111364","article-title":"Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/bs.ircmb.2024.08.005_bib186","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135168","article-title":"Serum miR-210 contributes to tumor detection, stage prediction and dynamic surveillance in patients with bladder cancer","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/bs.ircmb.2024.08.005_bib187","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/1354750X.2019.1634763","article-title":"Circulating adiponectin as a biomarker in renal cell carcinoma: A systematic review and meta-analysis","volume":"24","author":"Yap","year":"2019","journal-title":"Biomarkers: Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals"},{"issue":"6","key":"10.1016\/bs.ircmb.2024.08.005_bib188","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/1354750X.2019.1634763","article-title":"Circulating adiponectin as a biomarker in renal cell carcinoma: A systematic review and meta-analysis","volume":"24","author":"Yap","year":"2019","journal-title":"Biomarkers: Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib189","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.2147\/CMAR.S186108","article-title":"Urinary exosomal expression of long non-coding RNAs as diagnostic marker in bladder cancer","volume":"10","author":"Yazarlou","year":"2018","journal-title":"Cancer Management and Research"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib190","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bbrc.2022.09.056","article-title":"Exosomal microRNA-1 and MYO15A as a target for therapy and diagnosis in renal cell carcinoma","volume":"630","author":"Yoshino","year":"2022","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib191","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.599952","article-title":"IFI16 can be used as a biomarker for diagnosis of renal cell carcinoma and prediction of patient survival","volume":"12","author":"Yu","year":"2021","journal-title":"Frontiers in Genetics"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.08.005_bib192","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s43440-024-00568-7","article-title":"Diagnostic, prognostic, and therapeutic potential of exosomal microRNAs in renal cancer","volume":"76","author":"Yu","year":"2024","journal-title":"Pharmacological Reports: PR"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.08.005_bib193","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7150\/jca.37006","article-title":"A panel of urinary long non-coding RNAs differentiate bladder cancer from urocystitis","volume":"11","author":"Yu","year":"2020","journal-title":"Journal of Cancer"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib194","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1080\/07853890.2023.2172206","article-title":"A serum miRNAs signature for early diagnosis of bladder cancer","volume":"55","author":"Yu","year":"2023","journal-title":"Annals of Medicine"},{"issue":"5","key":"10.1016\/bs.ircmb.2024.08.005_bib195","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.3892\/ijo.2012.1622","article-title":"Cell-free microRNAs in urine as diagnostic and prognostic biomarkers of bladder cancer","volume":"41","author":"Yun","year":"2012","journal-title":"International Journal of Oncology"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.08.005_bib196","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4103\/2278-330X.187577","article-title":"Genitourinary cancers: Summary of Indian data","volume":"5","author":"Yuvaraja","year":"2016","journal-title":"South Asian Journal of Cancer"},{"issue":"5","key":"10.1016\/bs.ircmb.2024.08.005_bib197","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.4103\/jcrt.jcrt_1014_21","article-title":"Urinary microRNA-10a levels in diagnosis and prognosis of urinary bladder cancer","volume":"19","author":"Zaidi","year":"2023","journal-title":"Journal of Cancer Research and Therapeutics"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib198","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12943-018-0893-y","article-title":"Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer","volume":"17","author":"Zhan","year":"2018","journal-title":"Molecular Cancer"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.08.005_bib199","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5582\/bst.2016.01055","article-title":"iTRAQ-based quantitative proteomic analysis reveals potential early diagnostic markers of clear-cell Renal cell carcinoma","volume":"10","author":"Zhang","year":"2016","journal-title":"Bioscience Trends"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.08.005_bib200","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.18632\/oncotarget.6487","article-title":"Direct quantitative detection for cell-free miR-155 in urine: A potential role in diagnosis and prognosis for non-muscle invasive bladder cancer","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.08.005_bib201","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/jcmm.14042","article-title":"Evaluation of serum exosomal LncRNA\u2010based biomarker panel for diagnosis and recurrence prediction of bladder cancer.","volume":"23","author":"Zhang","year":"2019","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.08.005_bib202","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.euf.2016.09.007","article-title":"MicroRNAs in serum exosomes as potential biomarkers in clear-cell renal cell carcinoma","volume":"4","author":"Zhang","year":"2018","journal-title":"European Urology Focus"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib203","article-title":"iTRAQ-based quantitative proteomic analysis identified HSC71 as a novel serum biomarker for renal cell carcinoma","volume":"2015","author":"Zhang","year":"2015","journal-title":"BioMed Research International"},{"key":"10.1016\/bs.ircmb.2024.08.005_bib204","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117672","article-title":"Urinary-derived extracellular vesicle microRNAs as non-invasive diagnostic biomarkers for early-stage renal cell carcinoma","volume":"552","author":"Zhang","year":"2024","journal-title":"Clinica Chimica Acta:\u00a0International Journal of Clinical Chemistry"},{"issue":"35","key":"10.1016\/bs.ircmb.2024.08.005_bib205","doi-asserted-by":"crossref","first-page":"59527","DOI":"10.18632\/oncotarget.18521","article-title":"The prognostic and diagnostic value of circulating tumor cells in bladder cancer and upper tract urothelial carcinoma: A meta-analysis of 30 published studies","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/bs.ircmb.2024.08.005_bib206","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s12094-023-03374-4","article-title":"Exosomal noncoding RNAs as noninvasive biomarkers in bladder cancer: A diagnostic meta-analysis","volume":"26","author":"Zhao","year":"2024","journal-title":"Clinical & Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico"},{"issue":"10","key":"10.1016\/bs.ircmb.2024.08.005_bib207","first-page":"6475","article-title":"miR-625-3p promotes migration and invasion and reduces apoptosis of clear cell renal cell carcinoma","volume":"11","author":"Zhao","year":"2019","journal-title":"American Journal of Translational Research"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.005_bib208","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12943-018-0880-3","article-title":"Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression","volume":"17","author":"Zheng","year":"2018","journal-title":"Molecular Cancer"},{"issue":"10","key":"10.1016\/bs.ircmb.2024.08.005_bib209","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12032-014-0197-z","article-title":"Urinary cell-free microRNA-106b as a novel biomarker for detection of bladder cancer","volume":"31","author":"Zhou","year":"2014","journal-title":"Medical Oncology"}],"container-title":["International Review of Cell and Molecular Biology","Circulating biomarkers for diagnosis, prognosis and treatment response prediction in cancer \u2013 Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1937644824001229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1937644824001229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T10:33:06Z","timestamp":1762597986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1937644824001229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443345296"],"references-count":209,"URL":"https:\/\/doi.org\/10.1016\/bs.ircmb.2024.08.005","relation":{},"ISSN":["1937-6448"],"issn-type":[{"value":"1937-6448","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}